Stability studies needed to define the handling and transport conditions of sensitive pharmaceutical or biotechnological products

AAPS PharmSciTech

Volumn 12, Issue 4, 2011, Pages 1264-1275

  Ammann, Claude ^a  

^a Claude Ammann Consulting   (Switzerland)

Author keywords

biotechnological products; distribution; pharmaceutical products; stability; temperature excursions; transport

Indexed keywords

BIOTECHNOLOGICAL PRODUCTION; DRUG MANUFACTURE; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; GOOD MANUFACTURING PRACTICE; METHODOLOGY; PRIORITY JOURNAL; REVIEW; TEMPERATURE SENSITIVITY; THERMOREGULATION;

BIOLOGICAL FACTORS; BIOTECHNOLOGY; DRUG STABILITY; GUIDELINES AS TOPIC; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS; TRANSPORTATION;

EID: 83555168202     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9684-0     Document Type: Review

References (19)

1. Stability testing of new drug substances and products-Q1A (R2). (ICH), International Conference on Harmonization. Originally published 1994, revised 2003.
2. Stability testing: photostability testing of new drug substances and products-Q1B. (ICH), International Conference on Harmonization. 6 November 1996.
3. Stability testing for new dosage forms-Q1C. (ICH), International Conference on Harmonization. 6 November 1996.
4. Bracketing and matrixing designs for stability testing of new drug substances and products-Q1D. (ICH), International Conference on Harmonization. 7 February 2002.
5. Evaluation for stability data-Q1E. (ICH), International Conference on Harmonization. 6 February 2003.
6. Quality of biotechnological products: stability testing of biotechnological/biological products-Q5C. (ICH), International Conference on Harmonization. 30 November 1995.
7. Technical Report Series, No. 953: Annex 2 Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. WHO. 2009.
8. US Pharmacopoeia. USP. current version.
9. Technical Report no. 39: Cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. PDA. Originally published 2005, revised 2007.
10. Technical Report no. 46: Last mile: guidance for good distribution practices for pharmaceutical products to the end user. PDA. 2009.
11. Temperature controlled pharmaceutical distribution maintaining the quality of temperature sensitive products in the supply chain. Representative, FDA. Hotel Fira Palace, Barcelona: IBC Informa life sciences, 26-29 September 2006.
12. Temperature Controlled Pharmaceutical Distribution Conference. Representative, FDA. Amsterdam: IBC Informa life sciences, 9-10 October 2007.
13. Seevers RH, Bishara RH, Harber PJ, Lucas TI. Designing stability studies for time/temperature exposure. American Pharmaceutical Outsourcing. 2005; 6(5): 18, 20, 21, 23, 55
14. Lucas TI, Bishara RH, Seevers RH. A stability program for the distribution of drug products. pp. 68-73, s.l.: Pharmaceutical Technology, July 2004.
15. Guidelines for selecting and using ISTA test procedures and projects. ISTA. current.
16. International standards. ASTM. current.
17. Perishable cargo regulations, chapter 17 9th edition. IATA. July 2009.
18. Claude Ammann 2008 A mathematical approach to assessing temperature excursions in temperature-controlled chains European Journal of Parenteral and Pharmaceutical Sciences 13 2 57 59
19. Handbook of stability testing in pharmaceutical development regulations, methodologies, and best practices. Huynh-Ba, Kim (Ed.). s.l.: Springer, 2009.